SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-12-068153
Filing Date
2012-10-09
Accepted
2012-10-09 16:01:14
Documents
4
Period of Report
2012-10-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a12-23086_18k.htm 8-K 28699
2 EX-99.1 a12-23086_1ex99d1.htm EX-99.1 11035
3 EX-99.2 a12-23086_1ex99d2.htm EX-99.2 154507
4 GRAPHIC g230861mmi001.jpg GRAPHIC 2191
  Complete submission text file 0001104659-12-068153.txt   198660
Mailing Address 10110 SORRENTO VALLEY ROAD SUITE C SAN DIEGO CA 92121
Business Address 10110 SORRENTO VALLEY ROAD SUITE C SAN DIEGO CA 92121 8589090736
OPTIMER PHARMACEUTICALS INC (Filer) CIK: 0001142576 (see all company filings)

IRS No.: 330830300 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33291 | Film No.: 121135191
SIC: 2834 Pharmaceutical Preparations